Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC5901965/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC5901965/. The analysis below is for the second page.

Title[redir]:
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia - PMC
Description:
Imatinib, a selective BCR-ABL1 kinase inhibitor, improved the prognosis for patients with chronic myeloid leukemia (CML). We conducted efficacy and safety analyses on the basis of more than 10 years of follow-up in patients with CML who were treated ...

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,732,313 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Ncbi.nlm.nih.gov might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

patients, imatinib, response, doi, chronic, survival, leukemia, molecular, trial, years, google, scholar, cml, treatment, pubmed, interferon, myeloid, group, pharmaceuticals, phase, cytarabine, alfa, cytogenetic, rate, blood, therapy, study, pmc, months, novartis, article, major, receiving, longterm, estimated, followup, assigned, results, evaluated, bcrabl, complete, cancer, supplementary, appendix, death, rates, data, free, safety, high,

Topics {✒️}

quantitative rt-pcr assessments hematopoietic stem-cell transplantation promotes treatment-free remission stable treatment-free remission protocol nihms947077-supplement-protocol body-surface area daily attempt treatment-free remission pmc beta search bcr-abl1 tyrosine kinase complete cyto-genetic response long-term prognostic significance bcr-abl1 transcript levels pmc copyright notice long-term results presented philadelphia chromosome–positive leukemias low-risk sokal-score group 1056/nejmoa1609324 long-term outcomes long-term analyses included undetectable bcr-abl1 transcripts tyrosine kinase inhibitors subsequent progression-free survival stem cell transplantation single-institution historical experience long-term safety information randomized cml-study iv including braf-driven melanoma chronic myelogenous leukemia treatment-free remission chronic myeloid leukemia peripheral-blood platelet count newly diagnosed cml long-term survival data supplementary materials included medical research institute optimized high-dose imatinib sokal-score risk groups event-free survival [google scholar] 10 [google scholar] 35 disclosure forms provided long-term administration long-term outcome anderson cancer center white-cell count long-term benefits chronic phase improves long-term analyses knight cancer institute secondary malignant condition secondary malignant condition

Questions {❓}

  • Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia — is it all BCR-ABL?

Social Networks {👍}(6)

External Links {🔗}(90)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.51s.